|
|
|||
|
*Please read our disclaimer prior to accessing our research publications.* Golden Capital's Equity Research is only available to Canadian residents of provinces in which Golden Capital is licensed.
|
|
- Discontinued April 1st, 2004 - MicroCap Reports Second Quarter 2004 in PDF or Web format NEW First Quarter 2004 in PDF format or Web format Third Quarter 2003 in PDF format or Web format. Second Quarter 2003 in PDF format or Web format. First Quarter 2003 in PDF or Web format. Fourth Quarter 2002 in PDF or Web format. Third Quarter 2002 in PDF or Web format.
Research Reports August 7th, 2003 SynX Pharma (SYY-TSX) Research Report in PDF or Web format. June 19, 2002 SynX Pharma (SYY-TSX) Initiating Coverage. In PDF or Web format.
Research Updates February 10, 2004 SynX Pharma is acquired by Nanogen (NGEN-Q) for C$1.45. Webpage NEW August 28, 2003 SynX Pharma has in line Q2, and announces OCD funding. Webpage April 29, 2003 SynX Pharma reduces Q1 loss, expense reduction projected. Webpage March 26, 2003 SynX Pharma announces Q4 profit, but cash outlook is tight. Webpage January 27, 2003 SynX Pharma receives clearance for sale of TBI tests in Canada. Webpage January 21, 2003 SynX Pharma announces new candidate for Type 1 diabetes. Webpage November 29, 2002 SynX Pharma releases Q3 results, we update progress. Webpage November 19, 2002 SynX Pharma launches CHF test, profitable in Q4? Webpage October 16, 2002 SynX Pharma to market 70+ PBM tests in Canada. Webpage October 10, 2002 SynX Pharma and Ortho-Clinical (a J&J Co.) in Alzheimer's agreement. Web August 29, 2002 SynX Pharma releases surprisingly large Q2 loss. Outlook positive. Webpage August 28, 2002 SynX Pharma announces R&D agreement. Undisclosed partner. Webpage
To receive e-mail alerts when items are added to this page, click here.
To receive e-mail alerts when items are added to this page, click here.
|
